1. Home
  2. Analysis
  3. Aimovig
  4. Ceftriaxone

Aimovig and Ceftriaxone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aimovig (erenumab-aooe) and Ceftriaxone (ceftriaxone sodium). Common drug interactions include dementia among females.

The phase IV clinical study analyzes what interactions people have when they take Aimovig and Ceftriaxone. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

On Jul, 28, 2026

12 people who take Aimovig and Ceftriaxone together, and have interactions are studied.

Aimovig and Ceftriaxone drug interactions.

What are the common drug interactions of Aimovig and Ceftriaxone, by gender? *:

female:

  1. Dementia (madness)
  2. Infection
  3. Diarrhoea
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Nausea (feeling of having an urge to vomit)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Nonspecific reaction (unspecified reaction)
  8. Pneumonia
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Septic shock (shock due to blood infection)

male:

n/a

What are the common drug interactions of Aimovig and Ceftriaxone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Asthma
  2. Cardiac arrest
  3. Vomiting
  4. Cardiogenic shock (inadequate circulation of blood)
  5. Diarrhoea
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Pneumonia
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 6 people, 50.00%
  2. Essential Thrombocythaemia (chronic blood cancer): 3 people, 25.00%
  3. Migraine (headache): 2 people, 16.67%
  4. Primary Immunodeficiency Syndrome: 1 person, 8.33%
  5. Parkinson's Disease: 1 person, 8.33%
  6. Hallucinations (sensations that appear real but are created by your mind): 1 person, 8.33%
  7. Delusion (a false belief or opinion): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and Ceftriaxone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aimovig and Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aimovig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aimovig and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftriaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on erenumab-aooe and ceftriaxone sodium (the active ingredients of Aimovig and Ceftriaxone, respectively), and Aimovig and Ceftriaxone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.